Navigation Links
Cholesterol-lowering therapy benefits older people also

According to a new study it is observed that statins reduce the risk of heart attack in older people. Long-term treatment with statins lowers cholesterol// levels and so lowers the risk of heart disease. This has been shown to be the case in middle-aged people, but the benefits for the elderly have not been so clear.

Researchers at the University of Glasgow have assessed the benefit of treatment with the statin drug pravastatin in a group of 4,050 men and women aged between 75 and 80 years, all at high risk of heart attack or stroke. Half received pravastatin and half a placebo and all were followed up for an average of just over three years.

Pravastatin lowered low density lipoprotein (LDL, or 'bad' cholesterol) by about a third, and reduced a combination of coronary death, non-fatal heart attack and stroke by 16 per cent. Closer analysis shows that death from heart disease was reduced by 20 per cent, while stroke risk was unaffected. Lucidly, people of all ages can benefit from long-term statin therapy. All patients at high risk of heart disease should now be offered statins to improve their survival and future health.


'"/>




Page: 1

Related medicine news :

1. Cholesterol-lowering drug Found To greatly Reduce the risk of stroke and heart attack
2. Growing Popularity of Cholesterol-lowering Drugs Raises Concern
3. Cholesterol-lowering Drug Effective at Halting Early Atherosclerosis
4. Acupuncture May Help Chemotherapy Side Effects
5. Antioxidants protect health tissue in people undergoing radiation therapy.
6. Distraction therapy found very effective in postoperative patients
7. Acupuncture superseeds massage therapy for short term relief of pain
8. Ovarian cancer in relationship with Hormone therapy
9. New therapy better at increasing bone density
10. Gene therapy - Aim to improve blood flow
11. Gene therapy restores sight
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... ... 24, 2017 , ... Come to PAINWeekEnd (PWE) Tampa on May 20 and ... educational and exciting 2-day program. , An attendee at a recent PAINWeekEnd said, ... patients” about the course entitled Ain't Misbehavin': Decreasing and Managing Pain Patient Aberrant Behavior, ...
(Date:4/24/2017)... ... ... “Learning to Use Your SPIRITUAL COMPASS To Navigate Life Issues”: a guide to using ... Life Issues” is the creation of published author, Rachel Jamerson, writer of 25 years, ... USA, and former member of the American Association of Christian Counselors. Rachel studied ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... development of next generation neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke ... its ANCD BRAIN device as the product advances towards regulatory and clinical phases. ...
(Date:4/22/2017)... (PRWEB) , ... April 22, ... ... Administration of Eastern Pennsylvania has named PROSHRED® Security of Philadelphia its ... Heron-Doerr, PROSHRED® Philadelphia specializes in providing information destruction , recycling, ...
(Date:4/21/2017)... ... 2017 , ... Providing broad access to life-saving drugs and rewarding the innovators ... way to address this problem. , That was the message from Dana Goldman, PhD, ... the University of Southern California, who served as the keynote speaker for Western University ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, Inc. ... clinical-stage biopharmaceutical company developing new treatments for cancer ... closing of its previously announced underwritten public offering ... a public offering price of $2.00 per share, ... offering expenses payable by Sorrento.  The net proceeds ...
(Date:4/18/2017)... April 18, 2017  Cardinal Health (NYSE: ... fiscal 2017 earnings per share (EPS) guidance and providing ... is in conjunction with this morning,s announcement of the ... and Nutritional Insufficiency businesses. Cardinal Health now ... will be at the bottom of its previous guidance ...
(Date:4/18/2017)... BLOOMINGTON, Minn. , April 18, ... IMMY ) ("Imprimis"), an ophthalmology-focused pharmaceutical company, and ... today announced the signing of a three-year exclusive ... will deploy a dedicated sales team to introduce ... U.S., primarily focused in 13 states in the ...
Breaking Medicine Technology: